harvardbioscience.com (HBIO): Bathi saben saham sajrone rolas wulan pungkasan

Stable cash flow from laboratory pump sales creates a reliable foundation for Harvard Bioscience (HBIO). The rolling annual EPS trend clearly demonstrates this dynamic, where -2.62 characterizes this valuation parameter. Growth is driven by equipment deliveries to global universities, while high margins are achieved through the mass production of unique instruments for biomedical research.

HBIO Bathi resik saben saham sajrone patang kuartal pungkasan Harvard Bioscience Inc. (04.07.2022 - 12.11.2026)

Rincian analitis perusahaan harvardbioscience.com (HBIO)

- rega saham lan target rega konsensus:

Rega saham Harvard Bioscience|HBIO - Target median analis

- data kapitalisasi bursa:

Nilai pasar Harvard Bioscience, Inc.|HBIO - Nilai Bisnis

- data nilai buku modal saham:

Aset Bersih saben Siji Saham Harvard Bioscience|HBIO - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih harvardbioscience.com|HBIO - Aset Agregat Bisnis

- indikator beban utang lan likuiditas:

Utang marang Ekuitas Harvard Bioscience|HBIO - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Harvard Bioscience, Inc.|HBIO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Harvard Bioscience, Inc.|HBIO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Harvard Bioscience|Likuiditas cepet harvardbioscience.com

- data bathi lan kelipatan valuasi:

HBIO - Bathi perusahaan|Bathi mangsa ngarep Harvard Bioscience|HBIO - Rasio rega pasar marang bathi resik|Rega marang bathi mangsa ngarep Harvard Bioscience|HBIO - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Harvard Bioscience, Inc.|HBIO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Harvard Bioscience|HBIO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan harvardbioscience.com|HBIO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Harvard Bioscience

Analisis kabeh metrik perusahaan:HBIO - Harvard Bioscience

Harvard Bioscience is scaling its scientific equipment catalog by introducing organoid analysis systems to increase margins on B2B deals. By analyzing the TTM net income per share, an investor can see the business's actual earnings distributed across the total shares outstanding. This metric eliminates the influence of total capital volume, revealing the true efficiency of profit generation. The indicator's trend highlights resource accumulation phases during periods of market lull, allowing for an objective assessment of the asset's growth potential or stagnation risk.

Analisis pesaing